• Users Online: 53905
  • Home
  • Print this page
  • Email this page

    Article Cited by others

SYMPOSIUM

Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration

Gopal Lekha, Sharma Tarun

Year : 2007| Volume: 55| Issue : 6 | Page no: 431-435

   This article has been cited by
 
1 Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review
Yan Lv, Chenglei Zhai, Gang Sun, Yangfang He
Journal of Biological Engineering. 2024; 18(1)
[Pubmed]  [Google Scholar] [DOI]
2 Nanoformulations of flavonoids for diabetes and microvascular diabetic complications
Kopal Agarawal, Yogesh Anant Kulkarni, Sarika Wairkar
Drug Delivery and Translational Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Permeability, anti-inflammatory and anti-VEGF profiles of steroidal-loaded cationic nanoemulsions in retinal pigment epithelial cells under oxidative stress
Ana R. Fernandes, Tiago dos Santos, Pedro L. Granja, Elena Sanchez-Lopez, Maria L. Garcia, Amelia M. Silva, Eliana B. Souto
International Journal of Pharmaceutics. 2022; : 121615
[Pubmed]  [Google Scholar] [DOI]
4 Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Jose Navarro-Partida, Juan Carlos Altamirano-Vallejo, Luis Abraham Aceves Franco, Jesús Gonzalez-Cortes, Sergio Hernandez-Da Mota, Jose Gerardo García-Aguirre, Carlos David Azuara-Galindo, Carlos Rodrigo Castro-Castaneda, Juan Armendariz-Borunda, Arturo Santos
Pharmaceutics. 2021; 13(9): 1491
[Pubmed]  [Google Scholar] [DOI]
5 Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications
M.L. Formica, G.V. Ullio Gamboa, L.I. Tártara, J.D. Luna, J.P. Benoit, S.D. Palma
International Journal of Pharmaceutics. 2020; 573: 118795
[Pubmed]  [Google Scholar] [DOI]
6 Clearance of autophagy-associated dying retinal pigment epithelial cells – a possible source for inflammation in age-related macular degeneration
M Szatmári-Tóth, E Kristóf, Z Veréb, S Akhtar, A Facskó, L Fésüs, A Kauppinen, K Kaarniranta, G Petrovski
Cell Death & Disease. 2016; 7(9): e2367
[Pubmed]  [Google Scholar] [DOI]
7 Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells
Siva P. Kambhampati,Manoj K. Mishra,Panagiotis Mastorakos,Yumin Oh,Gerard A. Lutty,Rangaramanujam M. Kannan
European Journal of Pharmaceutics and Biopharmaceutics. 2015;
[Pubmed]  [Google Scholar] [DOI]
8 Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration
Anjali Hirani,Aditya Grover,Yong W. Lee,Yashwant Pathak,Vijaykumar Sutariya
Pharmaceutical Development and Technology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
9 Drug safety evaluation of intravitreal triamcinolone acetonide
Daniele Veritti, Andrea Di Giulio, Valentina Sarao, Paolo Lanzetta
Expert Opinion on Drug Safety. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
10 Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema
Taygan Yilmaz, Miguel Cordero-Coma, Thomas J Federici
Expert Opinion on Drug Metabolism & Toxicology. 2011; : 1
[HTML Full text]  [Google Scholar] [DOI]
11 Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment
Marieke Veurink, Cinzia Stella, Cyrus Tabatabay, Constantin J. Pournaras, Robert Gurny
European Journal of Pharmaceutics and Biopharmaceutics. 2011; 78(2): 271
[HTML Full text]  [Google Scholar] [DOI]
12 Intravitreal triamcinolone
Tao, Y., Jonas, J.B.
Ophthalmologica. 2010; 225(1): 1-20
[Pubmed]  [Google Scholar]
13 Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration
Tao, Y., Jonas, J.B.
Journal of Ocular Pharmacology and Therapeutics. 2010; 26(2): 207-211
[Pubmed]  [Google Scholar]
14 Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone for Therapy-Resistant Exudative Age-Related Macular Degeneration
Yong Tao,Jost B. Jonas
Journal of Ocular Pharmacology and Therapeutics. 2010; 26(2): 207
[Pubmed]  [Google Scholar] [DOI]
15 Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Criswell, M.H. and Hu, W.Z. and Steffens, T.J. and Li, R. and Margaron, P.
Archives of Ophthalmology. 2008; 126(7): 946
[Pubmed]  [Google Scholar]

 

Read this article